Investigator: Deborah Mash, PhD
St. Kitt, Virgin Islands
Sponsor: Healing Visions Institute for Addiction Recovery, Ltd.
Sponsor: Healing Visions Institute for Addiction Recovery, Ltd. Clinical study of the safety and efficacy of ibogaine in the treatment of addiction, with data gathered from patients treated by Dr. Mash, an expert in the study of ibogaine in human patient volunteers. To date, she has evaluated the effect of ibogaine in over three hundred patients. Due to a lack of funds, most of these data come from treatment conducted off-shore. This study is now completed, and Dr. Mash submitted data to FDA in 2007.
Sponsor: Healing Visions Institute for Addiction Recovery, Ltd.
Sponsor: Healing Visions Institute for Addiction Recovery, Ltd. Clinical study of the safety and efficacy of ibogaine in the treatment of addiction, with data gathered from patients treated by Dr. Mash, an expert in the study of ibogaine in human patient volunteers. To date, she has evaluated the effect of ibogaine in over three hundred patients. Due to a lack of funds, most of these data come from treatment conducted off-shore. This study is now completed, and Dr. Mash submitted data to FDA in 2007.
- Mash, D.C., Kovera, C.A. Pablo, J., Tyndale, R. F., Ervin, F.D., Williams, I.C., Singleton, E.G., and Mayor, M.
Ibogaine: Complex Pharmacokinetics, Concerns for Safety, and Preliminary Efficacy. Neurobiological Mechansisms of Drugs of Abuse, Annals New York Acad. Sci. Vol. 94: 394-401, 2000. - Mash DC, Kovera CA, Buck BE, Norenberg MD, Shapshak P, Hearn WL, Sanchez-Ramos J, (1998)
Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependence, Annals NY Acad Sci, v 844 pp 274-292.
